Warning: This security is no longer trading.
Novartis completes Medicines Company buyout
The Medicines Company (MDCO): Price and Financial Metrics
The Medicines Company (MDCO):
GET POWR RATINGS...
MDCO Stock Summary The capital turnover (annual revenue relative to shareholder's equity) for MDCO is -0.09 -- better than only 6.73% of US stocks. MDCO's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 0.54% of US stocks. Revenue growth over the past 12 months for Medicines Co comes in at -129.28%, a number that bests only 0.45% of the US stocks we're tracking. Stocks that are quantitatively similar to MDCO, based on their financial statements, market capitalization, and price volatility, are ABEO, MBIO, SYNA, JNCE, and ADAP. MDCO's SEC filings can be seen here. And to visit Medicines Co's official web site, go to www.themedicinescompany.com.
MDCO Price/Volume Stats
The Medicines Company (MDCO) Company Bio
The Medicines Company is a provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company was founded in 1996 and is based in Parsippany, New Jersey.
MDCO Latest News Stream
All News Types
Loading, please wait...
MDCO Price Returns
Page generated in 0.6769 seconds.